What is Monocacy Neurodevelopmental Center?
Monocacy Neurodevelopmental Center operates at the intersection of clinical excellence and community-based healthcare. Specializing in Autism Spectrum Disorder (ASD) treatment, the company provides comprehensive behavioral therapy designed to enhance communication, social interaction, and essential life skills. Based in Frederick, Maryland, the center distinguishes itself through a hybrid service model that integrates intensive behavior therapy with collaborative partnerships involving local school districts and regional organizations. By maintaining a focus on evidence-based ABA methodologies, the company ensures that its therapeutic interventions are both scalable and highly personalized, meeting the diverse needs of families across central Maryland while navigating the intricacies of insurance-backed healthcare delivery.
How much funding has Monocacy Neurodevelopmental Center raised?
Monocacy Neurodevelopmental Center has raised a total of $327K across 2 funding rounds:
Debt
$150K
Debt
$177K
Debt (2020): $150K with participation from PPP
Debt (2021): $177K led by PPP
Key Investors in Monocacy Neurodevelopmental Center
PPP
Public-Private Partnership
Undisclosed Investors
Undisclosed Investors
What's next for Monocacy Neurodevelopmental Center?
With the successful acquisition of this late-stage capital, Monocacy Neurodevelopmental Center is well-positioned to accelerate its operational expansion and enhance its service delivery infrastructure. The strategic deployment of these funds will likely focus on increasing clinical capacity, investing in staff development to maintain high-quality care standards, and potentially broadening its geographic reach within the mid-Atlantic region. As the organization continues to refine its service model, the focus will remain on optimizing patient outcomes through data-driven behavioral interventions. Furthermore, the center is expected to deepen its integration with regional healthcare networks, ensuring that its specialized services remain accessible and sustainable in an evolving regulatory and reimbursement landscape. This phase of growth marks a pivotal transition toward long-term institutional stability and market leadership in the neurodevelopmental healthcare space.
See full Monocacy Neurodevelopmental Center company page
